About: Modulation of gut microbiota through nutritional interventions in Behçet’s syndrome patients (the MAMBA study): study protocol for a randomized controlled trial

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Modulation of gut microbiota through nutritional interventions in Behçet’s syndrome patients (the MAMBA study): study protocol for a randomized controlled trial Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Modulation of gut microbiota through nutritional interventions in Behçet’s syndrome patients (the MAMBA study): study protocol for a randomized controlled trial
Creator	Becatti, Matteo Dinu, Monica Emmi, Giacomo Fiorillo, Claudia Pagliai, Giuditta Sofi, Francesco Turroni, Silvia
Source	Medline; PMC
abstract	BACKGROUND: Behçet’s syndrome (BS) is a systemic inflammatory disorder of unknown etiology, and it is characterized by a wide range of potential clinical manifestations. Recent evidence suggests that the gut microbiota (GM) in BS has low biodiversity with a significant depletion in butyrate producers. The aim of the present project is to investigate whether a dietary intervention could ameliorate the clinical manifestations and modulate the GM of individuals with BS. METHODS: This is a randomized, open, cross-over study that involves 90 individuals with BS, who will be randomly assigned to one of three different diets for 3 months: a lacto-ovo-vegetarian diet (VD), a Mediterranean diet (MD), or a Mediterranean diet supplemented with butyrate (MD-Bt). The VD will contain inulin-resistant and resistant-starch-rich foods, eggs, and dairy in addition to plant-based food, but it will not contain meat, poultry, or fish. The MD will contain all food categories and will provide two portions per week of fish and three portions per week of fresh and processed meat. The MD-Bt will be similar to the MD but supplemented with 1.8 g/day of oral butyrate. The three different diets will be isocaloric and related to the participants’ nutritional requirements. Anthropometric measurements, body composition, blood, and fecal samples will be obtained from each participant at the beginning and the end of each intervention phase. The primary outcomes will be represented by the change from baseline of the BS gastrointestinal and systemic symptoms. Changes from baseline in GM composition, short-chain fatty acid (SCFA) production, and the inflammatory and antioxidant profile will be considered as secondary outcomes. DISCUSSION: BS is a rare disease, and, actually, not all the available treatments are target therapies. A supportive treatment based on dietary and lifestyle issues, able to restore immune system homeostasis, could have a high impact on cost sustainability for the treatment of such a chronic and disabling inflammatory condition. TRIAL REGISTRATION: clinicaltrials.gov: NCT03962335. Registered on 21 May 2019.
has issue date	2020-06-09(xsd:dateTime)
bibo:doi	10.1186/s13063-020-04444-6
bibo:pmid	32517729
has license	cc-by
sha1sum (hex)	3b07da28dbbcb59f6e1f71b80f3e0c2708178664
schema:url	https://doi.org/10.1186/s13063-020-04444-6
resource representing a document's title	Modulation of gut microbiota through nutritional interventions in Behçet’s syndrome patients (the MAMBA study): study protocol for a randomized controlled trial
has PubMed Central identifier	PMC7282205
has PubMed identifier	32517729
schema:publication	Trials
resource representing a document's body	covid:3b07da28dbbcb59f6e1f71b80f3e0c2708178664#body_text
is schema:about of	named entity 'study' named entity 'SYNDROME' named entity 'GUT MICROBIOTA' named entity 'BIODIVERSITY' named entity 'gut microbiota' named entity 'gut microbiota' named entity 'Illumina MiSeq' named entity 'lipid peroxidation' named entity 'vegetarian' named entity 'informed consent' named entity 'principal coordinates analysis' named entity 'thiobarbituric acid reactive substances' named entity 'potatoes' named entity 'nutrient intake' named entity 'granulocyte-macrophage colony-stimulating factor' named entity 'cross-over studies' named entity 'GC-MS' named entity 'myocardial infarction' named entity 'etiology' named entity 'eating habits' named entity 'Shannon index' named entity 'clinicaltrials.gov' named entity 'inflammatory disorder' named entity 'butyrate' named entity 'fermentation' named entity 'randomly assigned' named entity 'ICMJE' named entity 'dietician' named entity 'clinical evaluation' named entity 'quality of life' named entity 'poultry' named entity 'nutritional requirements' named entity 'PERMANOVA' named entity 'metabolic' named entity 'multiple comparisons' named entity 'butyrate' named entity 'Nutrition' named entity 'Parabacteroides' named entity 'metabolites' named entity 'phylum' named entity 'plant-based food' named entity 'informed consent' named entity 'Urine samples' named entity 'butyrate' named entity 'IL-17' named entity 'mercapturic acid' named entity 'statistical analysis' named entity 'urine' named entity '7.5' named entity 'butyrate' named entity 'gut microbiota' named entity 'CD8' named entity 'cytokine' named entity 'blood analyses' named entity 'Alcoholic beverages' named entity 'clinical trial' named entity 'probiotic' named entity 'inflammatory condition' named entity 'metabolite' named entity 'pathogenesis' named entity 'G-CSF' named entity 'ad interim' named entity 'butyrate' named entity 'sample size' named entity 'abdominal bloating' named entity 'plastic bag' named entity 'Data analysis' named entity 'SCFA' named entity 'SSS' named entity 'Careggi' named entity 'muscle' named entity 'oxidative stress' named entity 'Adverse events' named entity 'butyrate' named entity 'tumor necrosis factor (TNF)-α'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software